COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,358 Articles (22,803 medRxiv, 8,555 bioRxiv)

Most recent first Previous |  Page 1754: Articles 17531-17540  | Next

Long-read sequencing of SARS-CoV-2 reveals novel transcripts and a diverse complex transcriptome landscape.
Li-Pook-Than, J., Banuelos, S., Honkala, A., Sahoo, M. K., Pinsky, B. A., Snyder, M. P.
10.1101/2021.03.05.434150 — Posted: 2021-03-06
SARS-CoV-2 surveillance in Norway rats (Rattus norvergicus) from Antwerp sewer system, Belgium
Colombo, V. C., Sluydts, V., Marien, J., Vanden Broecke, B., Van Houtte, N., Leirs, W., Jacobs, L., Iserbyt, A., Hubert, M., Heyndrickx, L., Goris, H., Delputte, P., De Roeck, N., Elst, J., Boudewijns, R., Arien, K., Leirs, H., Gryseels, S.
10.1101/2021.03.06.433708 — Posted: 2021-03-06
SARS-CoV-2-host chimeric RNA-sequencing reads do not necessarily signify virus integration into the host DNA
Kazachenka, A., Kassiotis, G.
10.1101/2021.03.05.434119 — Posted: 2021-03-05
Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID 19) Virus-Neutralizing Antibodies in Human Clinical Samples
Holbrook, M. R., Bennett, R. S., Postnikova, E. N., Liang, J., Gross, R., Gerhardt, D., Georgia-Clark, S., Cai, Y., Yu, S., Marron, L., Kocher, G., Mazur, S., Dixit, S., Lukin, V. V.
10.1101/2021.03.05.434152 — Posted: 2021-03-05
Analysis of SARS-CoV-2 Mutations Over Time Reveals Increasing Prevalence of Variants in the Spike Protein and RNA-Dependent RNA Polymerase
Showers, W. M., Leach, S. M., Kechris, K., Strong, M.
10.1101/2021.03.05.433666 — Posted: 2021-03-05
Scent dog identification of SARS-CoV-2 infections, similar across different body fluids
Jendrny, P., Twele, F., Meller, S., Schulz, C., von Koeckritz-Blickwede, M., Osterhaus, A., Ebbers, H., Ebbers, J., Pilchova, V., Pink, I., Welte, T., Manns, M. P., Fathi, A., Addo, M. M., Ernst, C., Schaefer, W., Engels, M., Petrov, A., Marquart, K., Schotte, U., Schalke, E., Volk, H. A.
10.1101/2021.03.05.434038 — Posted: 2021-03-05 Discussion: Onsite | Offsite
Neutralization heterogeneity of United Kingdom and South-African SARS CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers
Marot, S. S., Malet, I., Jary, A., Leducq, V., Abdi, B., Teyssou, E., Soulie, C., Wirden, M., Rodriguez, C., Fourati, S., Pawlotsky, J.-M., Boutolleau, D., Burrel, S., Calvez, V., Marcelin, A.-G.
10.1101/2021.03.05.434089 — Posted: 2021-03-05
Previous SARS-CoV-2 infection increases B.1.1.7 cross-neutralization by vaccinated individuals.
Trinite, B., Pradenas, E., Marfil, S., Rovirosa, C., Urrea, V., Tarres-Freixas, F., Ortiz, R., Vergara-Alert, J., Segales, J., Guallar, V., Lepore, A., Izquierdo-Useros, N., Trujillo, G., Trape, J., Gonzalez-Fernandez, C., Flor, A., Perez-Vidal, R., Chamorro, A., Toledo, R., Paredes, R., Blanco, I., Grau, E., Massanella, M., Carrillo, J., Clotet, B., Blanco, J.
10.1101/2021.03.05.433800 — Posted: 2021-03-05
Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2
Tayeb-Fligelman, E., Cheng, X., Tai, C., Bowler, J. T., Griner, S., Sawaya, M. R., Seidler, P. M., Jiang, Y. X., Lu, J., Rosenberg, G. M., Salwinski, L., Abskharon, R., Zee, C.-T., Hou, K., Li, Y., Boyer, D., Murray, K. A., Falcon, G., Anderson, D. H., Cascio, D., Saelices, L., Damoiseaux, R., Guo, F., Eisenberg, D.
10.1101/2021.03.05.434000 — Posted: 2021-03-05
A Two-Sample Robust Bayesian Mendelian Randomization Method Accounting for Linkage Disequilibrium and Idiosyncratic Pleiotropy With Applications to the COVID-19 Outcome
Wang, A., Liu, Z.
10.1101/2021.03.02.21252801 — Posted: 2021-03-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).